Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s SFDA Creates New Regulations And System To Monitor Medical Device Adverse Events

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State FDA has issued new regulations on the reporting and monitoring of adverse events tied to medical devices

You may also be interested in...



Insider Analysis From Asia Pacific Bio Intelligence LLC On China State FDA’s Medical Device Regulations

For China’s State FDA, 2011 was a banner year, with regulations released on good manufacturing practices for both drugs and devices. Multinational companies should take notice and be sure their operations are in compliance.

China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices

BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation

China’s MOH-SFDA Merger: Analysts Weigh In

SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing

Related Content

UsernamePublicRestriction

Register

LL021506

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel